1. Scrip

Bristol’s Boerner To Succeed CEO Caforio With Launch Execution In The Spotlight

 
• By Jessica Merrill

Giovanni Caforio will step down as CEO of Bristol Myer Squibb effective 1 November, with chief commercialization officer Boerner primed to succeed him.

Bristol Myers Squibb
Bristol announced a leadership transition • Source: Bristol Myers Squibb (ROBERT BRUSCHINI IM GES LLC)

Bristol Myers Squibb Company’s next CEO will be chief commercialization officer Christopher Boerner, who has been readied to take the top spot at the big pharma. CEO Giovanni Caforio will step down from the leadership role effective 1 November, although he will continue to serve as executive chairman for a transition period.

The company announced what it is expected to be a smooth leadership transition after market close on 26 April, one day ahead of the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.